References
- Prosepctive Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 45,000 people in 45 prospective cohorts. Lancet 1995; 346: 1647–1653, [CSA]
- MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765–774, [CSA], [CROSSREF]
- Collins R, Peto R, Mar-Mahon S, Hebert P, Fiebich NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838, [CSA], [CROSSREF]
- Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13–18, [CSA], [CROSSREF]
- Sytkowski PA, D’Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 1996; 93: 697–703, [CSA]
- Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 1995; 25: 305–313, [CSA]
- Guidelines Subcommittee. 1999 World Health Organization–International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151–183, [CSA]
- Chobanian AV, Bakris GL, Black HR. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572, [CSA], [CROSSREF]
- Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Quadra B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957–1963, [CSA], [CROSSREF]
- Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood-pressure control in the hypertensive population. Lancet 1997; 349: 454–457, [CSA], [CROSSREF]
- Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GL, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413–423, [CSA], [CROSSREF]
- Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England—results from the health survey for England 1994. J Hypertens 1998; 16: 747–752, [CSA], [CROSSREF]
- Wang Z, Wu Y, Zhao L, Li Y, Yang J, Zhou B. Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992–1998. Hypertens Res 2004; 27: 703–709, [CSA], [CROSSREF]
- Tao SQ, Wu XG, Duan XF, Fang WQ, Hao JS, Fan DJ, Wang WZ, Li Y. Hypertension prevalence and status of awareness, treatment and control in China. Chinese Med J 1995; 108: 483–489, [CSA]
- Management of patient compliance in the treatment of hypertension: report of the NHLBI Working Group. Hypertension 1982; 4: 415–423, [CSA]
- Wang LX. Physician-related barriers to hypertension management. Med Prin Pract 2004; 13: 282–285, [CSA], [CROSSREF]
- Chobanian AV. Control of hypertension—an important national priority. N Engl J Med 2001; 345: 534–535, [CSA], [CROSSREF]
- Douglas JG, Ferdinand KC, Bakris GL, Sowers JR. Barriers to blood pressure control in African Americans—overcoming obstacles is challenging, but goals can be attained. Postgrad Med 2002; 112: 51–56, [CSA]
- Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Menard J, Rahn KH, Wedel H, Westerling S, for the HOT study group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755–1762, [CSA], [CROSSREF]